246 related articles for article (PubMed ID: 25220556)
1. Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients.
Beumier M; Casu GS; Hites M; Wolff F; Cotton F; Vincent JL; Jacobs F; Taccone FS
Minerva Anestesiol; 2015 May; 81(5):497-506. PubMed ID: 25220556
[TBL] [Abstract][Full Text] [Related]
2. β-lactam antibiotic concentrations during continuous renal replacement therapy.
Beumier M; Casu GS; Hites M; Seyler L; Cotton F; Vincent JL; Jacobs F; Taccone FS
Crit Care; 2014 May; 18(3):R105. PubMed ID: 24886826
[TBL] [Abstract][Full Text] [Related]
3. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
[TBL] [Abstract][Full Text] [Related]
4. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
Seyler L; Cotton F; Taccone FS; De Backer D; Macours P; Vincent JL; Jacobs F
Crit Care; 2011; 15(3):R137. PubMed ID: 21649882
[TBL] [Abstract][Full Text] [Related]
5. Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.
Udy AA; Varghese JM; Altukroni M; Briscoe S; McWhinney BC; Ungerer JP; Lipman J; Roberts JA
Chest; 2012 Jul; 142(1):30-39. PubMed ID: 22194591
[TBL] [Abstract][Full Text] [Related]
6. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
[TBL] [Abstract][Full Text] [Related]
7. Can changes in renal function predict variations in β-lactam concentrations in septic patients?
Casu GS; Hites M; Jacobs F; Cotton F; Wolff F; Beumier M; De Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2013 Nov; 42(5):422-8. PubMed ID: 23993066
[TBL] [Abstract][Full Text] [Related]
8. What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling.
Delattre IK; Hites M; Laterre PF; Dugernier T; Spapen H; Wallemacq PE; Jacobs F; Taccone FS
Int J Antimicrob Agents; 2020 Oct; 56(4):106113. PubMed ID: 32721604
[TBL] [Abstract][Full Text] [Related]
9. Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Hites M; Taccone FS; Wolff F; Cotton F; Beumier M; De Backer D; Roisin S; Lorent S; Surin R; Seyler L; Vincent JL; Jacobs F
Antimicrob Agents Chemother; 2013 Feb; 57(2):708-15. PubMed ID: 23147743
[TBL] [Abstract][Full Text] [Related]
10. β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance.
Jacobs A; Taccone FS; Roberts JA; Jacobs F; Cotton F; Wolff F; Creteur J; Vincent JL; Hites M
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987138
[TBL] [Abstract][Full Text] [Related]
11. Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
Lheureux O; Trepo E; Hites M; Cotton F; Wolff F; Surin R; Creteur J; Vincent JL; Gustot T; Jacobs F; Taccone FS
Liver Int; 2016 Jul; 36(7):1002-10. PubMed ID: 26645828
[TBL] [Abstract][Full Text] [Related]
12. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
13. Neurological burden and outcomes of excessive β-lactam serum concentrations of critically ill septic patients: a prospective cohort study.
Zerbib Y; Gaulin C; Bodeau S; Batteux B; Lemaire-Hurtel AS; Maizel J; Kontar L; Bennis Y
J Antimicrob Chemother; 2023 Nov; 78(11):2691-2695. PubMed ID: 37694500
[TBL] [Abstract][Full Text] [Related]
14. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
Abdulla A; Ewoldt TMJ; Hunfeld NGM; Muller AE; Rietdijk WJR; Polinder S; van Gelder T; Endeman H; Koch BCP
BMC Infect Dis; 2020 Jan; 20(1):57. PubMed ID: 31952493
[TBL] [Abstract][Full Text] [Related]
15. Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course.
Carlier M; Carrette S; Stove V; Verstraete AG; De Waele JJ
Int J Antimicrob Agents; 2014 May; 43(5):470-3. PubMed ID: 24685990
[TBL] [Abstract][Full Text] [Related]
16. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
[TBL] [Abstract][Full Text] [Related]
17. High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied.
Woksepp H; Hällgren A; Borgström S; Kullberg F; Wimmerstedt A; Oscarsson A; Nordlund P; Lindholm ML; Bonnedahl J; Brudin L; Carlsson B; Schön T
Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):553-563. PubMed ID: 27815778
[TBL] [Abstract][Full Text] [Related]
18. Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships.
Imani S; Buscher H; Marriott D; Gentili S; Sandaradura I
J Antimicrob Chemother; 2017 Oct; 72(10):2891-2897. PubMed ID: 29091190
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
Delattre IK; Musuamba FT; Jacqmin P; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq P
Clin Biochem; 2012 Jul; 45(10-11):780-6. PubMed ID: 22503878
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept.
Roberts JA; Ulldemolins M; Roberts MS; McWhinney B; Ungerer J; Paterson DL; Lipman J
Int J Antimicrob Agents; 2010 Oct; 36(4):332-9. PubMed ID: 20685085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
